# Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients

> **NCT03712371** · PHASE1,PHASE2 · TERMINATED · sponsor: **Medical University of South Carolina** · enrollment: 12 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Chitosan

## Key facts

- **NCT ID:** NCT03712371
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-16
- **Primary completion:** 2020-07-02
- **Final completion:** 2021-09-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Interim study results were not favorable to continue with further enrollment.
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03712371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03712371, "Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03712371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*